Human Clostridium difficile infection: altered mucus production and composition
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The majority of antibiotic-induced diarrhea is caused by Clostridium difficile ( C. difficile). Hospitalizations for C. difficile infection (CDI) have tripled in the last decade, emphasizing the need to better understand how the organism colonizes the intestine and maintain infection. The mucus provides an interface for bacterial-host interactions and changes in intestinal mucus have been linked host health. To assess mucus production and composition in healthy and CDI patients, the main mucins MUC1 and MUC2 and mucus oligosaccharides were examined. Compared with healthy subjects, CDI patients demonstrated decreased MUC2 with no changes in surface MUC1. Although MUC1 did not change at the level of the epithelia, MUC1 was the primary constituent of secreted mucus in CDI patients. CDI mucus also exhibited decreased N-acetylgalactosamine (GalNAc), increased N-acetylglucosamine (GlcNAc), and increased terminal galactose residues. Increased galactose in CDI specimens is of particular interest since terminal galactose sugars are known as C. difficile toxin A receptor in animals. In vitro, C. difficile is capable of metabolizing fucose, mannose, galactose, GlcNAc, and GalNAc for growth under healthy stool conditions (low Na+concentration, pH 6.0). Injection of C. difficile into human intestinal organoids (HIOs) demonstrated that C. difficile alone is sufficient to reduce MUC2 production but is not capable of altering host mucus oligosaccharide composition. We also demonstrate that C. difficile binds preferentially to mucus extracted from CDI patients compared with healthy subjects. Our results provide insight into a mechanism of C. difficile colonization and may provide novel target(s) for the development of alternative therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200 · cited 3×
“acetylglucosamine (GlcNAc), galactose (Gal), N-acetylgalactosamine (GalNAc), fucose (Fuc), 325 N-acetylneuraminic acid (NeuNAc), and mannose (53-55) are attached to mucin glycoproteins 326 and can be used by bacteria to maintain their relative niches.”
BackgroundMucin dynamics and enteric pathogens
McGuckin, M. A., Lindén, S. K., Sutton, P., & Florin, T. H. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2538 · Cited by 1,428 · cited 3×
“Secreted and adherent mucus are 72 continuously renewed and can be rapidly secreted by the host to limit host-bacterial interaction 73 (65, 71).”
BackgroundEnteric defensins are essential regulators of intestinal microbial ecology
Salzman, N. H., Hung, K., Haribhai, D., Chu, H., Karlsson-Sjöberg, J., Amir, E., Teggatz, P., Barman, M., Hayward, M., Eastwood, D., et al. (2010) · Nature Immunology · doi:10.1038/ni.1825 · Cited by 1,156
The indigenous gastrointestinal microflora
Berg, R. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10057-3 · Cited by 1,153 · cited 1×
“In addition to serving as a barrier, the mucus serves as an interface between the bacteria and the host: the mucus provides binding sites for both commensal and pathogenic bacteria (64, 87) and bacterial energy/food sources (2, 6, 26, 107).”
BackgroundMicrobiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Ng, K. M., Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B. C., Monack, D. M., et al. (2013) · Nature · doi:10.1038/nature12503 · Cited by 1,035
Microbial modulation of innate defense: goblet cells and the intestinal mucus layer
Deplancke, B., & Gaskins, H. R. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.6.1131s · Cited by 1,012 · cited 5×
“In addition to serving as a barrier, the mucus serves as an interface between the bacteria and the host: the mucus provides binding sites for both commensal and pathogenic bacteria (64, 87) and bacterial energy/food sources (2, 6, 26, 107).”
BackgroundInfluentialBergstrom, K. S. B., Kissoon-Singh, V., Gibson, D. L., Ma, C., Montero, M., Sham, H. P., Ryz, N., Huang, T., Velcich, A., Finlay, B. B., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000902 · Cited by 625 · cited 4×
“The mucus barrier has been shown to provide partial protection against several enteric bacterial pathogens, including Yersinia enterocolitica, Shigella flexneri, Citrobacter rodentium, and Salmonella enterica Serovar Typhimurium (8, 69, 76, 107).”
BackgroundInfluentialLoss of intestinal core 1–derived O-glycans causes spontaneous colitis in mice
Fu, J., Wei, B., Wen, T., Johansson, M. E. V., Liu, X., Bradford, E., Thomsson, K. A., McGee, S., Mansour, L., Tong, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45538 · Cited by 366 · cited 1×
“qRT-PCR was performed using SYBR Green PCR master mix (ABI) on a 251 Step One Real Time PCR Machine (ABI) with the following gene specific qRT-PCR primers 252 were derived from previous literature: Muc1 Forward 5'- CCAGACCCCTGCACTCTGAT-3', 253 Muc1 Reverse 5'- CGCTTGACAAAGGGCATGA-3'; Muc2 Forward5'254 TGCCCACCTCCTCAAA…”
Method
Cited by
Grondin, J. A., Kwon, Y. H., Far, P. M., Haq, S., & Khan, W. I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02054 · Cited by 465
The role of the microbiota in infectious diseases
Libertucci, J., & Young, V. B. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0278-4 · Cited by 357
Gut Microbiota and Intestinal Trans-Epithelial Permeability
Allam-Ndoul, B., Castonguay-Paradis, S., & Veilleux, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176402 · Cited by 351
Zachos, N. C., Kovbasnjuk, O., Foulke-Abel, J., In, J., Blutt, S. E., de Jonge, H. R., Estes, M. K., & Donowitz, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.635995 · Cited by 297
Engevik, M. A., Luk, B., Chang-Graham, A. L., Hall, A., Herrmann, B., Ruan, W., Endres, B. T., Shi, Z., Garey, K. W., Hyser, J. M., et al. (2019) · mBio · doi:10.1128/mbio.01087-19 · Cited by 269
Self-citationBhinder, G., Allaire, J. M., Garcia, C., Lau, J. T., Chan, J. M., Ryz, N. R., Bosman, E. S., Graef, F. A., Crowley, S. M., Celiberto, L. S., et al. (2017) · Scientific Reports · doi:10.1038/srep45274 · Cited by 178
Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut–Brain Axis
Engevik, M. A., Luck, B., Visuthranukul, C., Ihekweazu, F. D., Engevik, A. C., Shi, Z., Danhof, H. A., Chang-Graham, A. L., Hall, A., Endres, B. T., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.08.002 · Cited by 164
Self-citationHuman mini-guts: New insights into intestinal physiology and host–pathogen interactions
In, J. G., Foulke-Abel, J., Estes, M. K., Zachos, N. C., Kovbasnjuk, O., & Donowitz, M. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.142 · Cited by 125
Intestinal organoids: A new paradigm for engineering intestinal epithelium in vitro
Rahmani, S., Breyner, N. M., Su, H.-M., Verdu, E. F., & Didar, T. F. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.006 · Cited by 98
Farewell to Animal Testing: Innovations on Human Intestinal Microphysiological Systems
Kang, T., & Kim, H. (2016) · Micromachines · doi:10.3390/mi7070107 · Cited by 40
Metadata
- Authors
- Engevik, M. A., Yacyshyn, M. B., Engevik, K. A., Wang, J., Darien, B., Hassett, D. J., Yacyshyn, B. R., & Worrell, R. T.
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2015-03-15
- Volume
- 308
- Issue
- 6
- Pages
- G510-G524
- ISSN
- 0193-1857 (ISSN-L)
- 1522-1547
- OpenAlex
- W2117098504
- Cited by
- 135
- References
- 8
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.